Investigation of Metformin Contamination in Horses: Implications for Environmental Exposure and Doping Control.

Objective Overview

• This study investigates how horses can become contaminated with metformin, a human diabetes drug, through environmental exposure rather than direct administration.
• It assesses the implications of this contamination for doping control in racehorses, where metformin detection can trigger regulatory actions.

Background and Motivation

• Metformin is widely used to treat type 2 diabetes in humans.
• The drug has minimal therapeutic benefit in veterinary medicine, particularly for horses.
• Despite this, recent testing has found metformin residues in racehorse samples, raising concerns over whether the horses were deliberately treated or inadvertently exposed.
• Metformin is known to be excreted unchanged in human urine, and it does not degrade easily in the environment, which can lead to contamination of surfaces such as bedding or shavings in stables.
• Understanding the contamination pathways is crucial to prevent false doping violations and to ensure fair regulation in equine sports.

Study Design and Methods

• Six horses were experimentally exposed to shavings contaminated with urine containing metformin at three different concentrations: 10, 135, and 270 μg/mL.
• Samples of blood (including plasma, serum, whole blood, and red blood cells) and urine were collected from the horses over a 168-hour (7-day) period following exposure.
• Metformin concentrations in these biological samples were measured to determine how contamination affected systemic absorption and excretion.

Key Findings

• Metformin was detectable in the blood of all horses at least once during the collection period, confirming that environmental contamination can result in measurable systemic exposure.
• Urine samples showed metformin concentrations significantly higher than those found in blood samples, indicating accumulation or passage through the urinary system after exposure.
• Metformin could be detected in urine as early as 4 hours post-exposure, showing rapid uptake and excretion.

Implications and Conclusions

• The study demonstrates that environmental contamination, such as exposure to urine-contaminated bedding, can lead to detectable levels of metformin in horses without intentional administration.
• This finding is significant because it challenges the interpretation of metformin positives in doping controls — not all detections necessarily indicate deliberate doping.
• It highlights the need for regulatory bodies to consider environmental exposure pathways when setting rules and thresholds for metformin detection in racehorses.
• Stable management practices, including regular cleaning and monitoring, may be important to minimize inadvertent contamination risks.